MERCK & CO., INC Rahway, NJ, USA
(known as MSD outside the United States and Canada)

Effective Nov. 20th, 2023 Caraway Therapeutics, Inc.,
a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

View the Announcement Visit

Board of Directors

Christian Schubert, PhD
Christian Schubert, PhD
Board Director

Christian Schubert, PhD, has over 10 years’ experience in the life sciences industry spanning corporate development, strategy and external innovation, company building, and venture capital.

Dr. Schubert is currently Vice President and Head of AbbVie Ventures, where he directs AbbVie’s strategic venture capital investments in core therapeutic areas of interest. Prior to joining AbbVie Ventures, he was an Entrepreneur in Residence (EIR) at Atlas Venture where he helped conceive, launch, and operate next generation biotechnology companies. Prior to his role at Atlas, Dr. Schubert was the Global Head of R&D External Innovation at Servier and Managing Director of Servier BioInnovation, and earlier in his career held roles in Corporate Development and Strategy at Biogen and Worldwide R&D at Pfizer.

Dr. Schubert holds BSc and MSc degrees from the Technical University of Munich, received his PhD from Massachusetts Institute of Technology, and completed a postdoctoral fellowship at Harvard Medical School and Boston Children’s Hospital.